Stock News

Merck and Bayer’s Investigational Drug Vericiguat Meets Primary Endpoint in Phase 3 Study of Patients with Worsening Chronic Heart Failure
Thiel Marks Palantir’s Asia Push with $150 Million Japan Venture
Hedge Funds Open Kimono: 5 Best Healthcare Stocks To Buy
BRAVECTO® PLUS (fluralaner and moxidectin topical solution) for Cats Receives Approval from US Food and Drug Administration
Merck KGaA CFO on M&A Hiatus, Third-Quarter Earnings
Cisco, Merck share losses lead Dow's nearly 75-point drop
US FDA Accepts Regulatory Submission of New Drug Application for Selumetinib in Neurofibromatosis Type 1 (NF1) and Grants Priority Review
UPDATE 2-Merck KGaA raises 2019 guidance after Versum takeover
Dow flat despite gains in Procter & Gamble, Coca-Cola shares

As seen on...